P21
P21 is a small synthetic peptidomimetic derived from a four-residue active fragment of ciliary neurotrophic factor (CNTF), in which an adamantane-modified residue — the "(A)" position in the notation Ac-DGGL(A)G-NH2 — stands in place of an ordinary amino acid, N-acetylated and C-terminally amidated.

Identity & structure
Primary sequence · 6 residues · N-terminal Acetyl · C-terminal amide · Position 5 (Ada) is an adamantane-modified residue and is shown as a single non-standard token, not alanine; the adamantane group is a side-chain modification, not a standard amino acid.
| Identity | |
|---|---|
| CAS | 1246751-68-7 |
| PubChem CID | 56589645 |
| Also known as | P021, Peptide 021, Peptide 21, P21 peptide |
| Research class | Signaling & Neuroactive |
| Structure | |
| Molecular formula | C27H42N6O8 |
| InChIKey | LUJZBZPLIRWWGJ-NBONATBJSA-N |
| Sequence | Ac-DGGL(A)G-NH2 |
| Length | 6 residues |
| Analytical | |
| Average molecular weight | 578.67 g/mol |
| Monoisotopic mass | 578.3064 Da (computed) |
P21 is written Ac-DGGL(A)G-NH2, where the "(A)" at position 5 is not an alanine but an adamantane-based amino-acid residue — a compact, highly lipophilic cage carried on the backbone. The peptide is N-acetylated at the N-terminus and bears a primary amide at the C-terminus. Its stereodescriptor-bearing InChIKey, LUJZBZPLIRWWGJ-NBONATBJSA-N, was machine-verified against PubChem CID 56589645 at build (formula C27H42N6O8), so the molecular identity is reconciled. A computed 3D conformer is deliberately withheld: PubChem carries no 3D record for this compound and leaves two carbons of the adamantyl cage stereochemically undefined, so embedding one would force a chirality the source record does not assert. The residue-chain schematic is drawn, with the adamantane unit shown as a single non-standard token rather than a standard backbone amino acid — the deposited structure resolves it as one cage bearing both the backbone amide and the C-terminal carboxamide, which does not map cleanly onto a linear per-residue chain.
Reference context
P21 is a small synthetic peptidomimetic derived from a four-residue active fragment of ciliary neurotrophic factor (CNTF), in which an adamantane-modified residue — the "(A)" position in the notation Ac-DGGL(A)G-NH2 — stands in place of an ordinary amino acid, N-acetylated and C-terminally amidated. It is listed here strictly as an analytical reference entity — it is not sold, stocked, or certified by Lineará, and has no price or certificate of analysis. The data on this page is characterization only: molecular formula C27H42N6O8 and the values computed from it. No biological activity, mechanism, or use is described or implied.
Listed solely as a characterized analytical reference — no representation is made as to any biological effect. For Research Use Only — not for human or veterinary use.
How P21 is characterized
Identity rests on the molecular formula and mass. Electrospray mass spectrometry (ESI-MS) measures the mass-to-charge ratio of the intact molecule; the average and monoisotopic masses are computed from the verified formula and cross-check the composition. The residue sequence and the modifications noted above define the structure.
Frequently asked questions
What is P21?
What is the amino-acid sequence of P21?
What is the molecular formula of P21?
What are the key chemical identifiers for P21?
Is P21 a peptide?
How is P21 stored and reconstituted?
Does Lineará sell P21?
Is P21 approved for human use?
Data, tools & related references
References
- PubChem — compound identity, structure & computed properties (CID 56589645). PubChem →
- CAS Registry Number 1246751-68-7.
Research professionals only
Reference data
This monograph is characterization reference data. Lineará does not sell, stock, or certify P21.